20 results
·
21ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
ARIX Sternal System
FDA 510(k)
FDA Class 2
·Orthopedic
NITREX
FDA UDI
Covidien LP·00821684058190·Guidewire
NITREX™
FDA UDI
EV3, INC·00763000185435·GW N181806 NITREX V04
NITREX
FDA UDI
Covidien LP·10821684009090·Guidewire
PILLING
FDA UDI
TELEFLEX INCORPORATED·24026704512878·
restor3d Utility Wedge
FDA UDI
Restor3d, Inc.·00840097504933·Ti Anatomic Evans Wedge, Small Footprint, 6mm T...
Origin Short Neck Collared Hip Stem
FDA UDI
SIGNATURE ORTHOPAEDICS PTY LTD·09348215024017·
SiNAPTIC Osteotomy Wedge System
FDA UDI
SINTX Technologies, Inc.·G817S101181806·Evans Wedge, 18W x 18D x 6H
AIDERA DIASEND SYSTEM
FDA 510(k)
FDA Class 2
·General Hospital
IDI IMPLANT SYSTEM
FDA 510(k)
FDA Class 2
·Dental
311NNM NARROWAND UV PHTOTHERAPY LIGHT LAMP
FDA Adverse Event
Injury
·XUZHOU KERNEL MEDICAL INSTRUMENT EQUIPMENT CO LTD.·Product code FTC·December 22, 2022
SHOULDER SYSTEM
FDA Adverse Event
Injury
·MEDACTA INTERNATIONAL SA·Product code PHX·July 28, 2025
COLLEAGUE PRE P1.7
FDA Adverse Event
Malfunction
·BAXTER HEALTHCARE - SINGAPORE·Product code FRN·July 27, 2011
SYNCHROMED II
FDA Adverse Event
Injury
·MDT PUERTO RICO OPERATIONS CO·Product code LKK·June 21, 2013
GE OEC 9900
FDA Adverse Event
Malfunction
·GE OEC MEDICAL SYSTEMS INC·Product code JAA·September 19, 2008
SHOULDER SYSTEM
FDA Adverse Event
Injury
·MEDACTA INTERNATIONAL SA·Product code PHX·October 8, 2025
REVERSE SHOULDER SYSTEM GLENOID POLYAXIAL NON-LOCKING SCREW - L46
FDA Adverse Event
Injury
·MEDACTA INTERNATIONAL SA·Product code PHX·July 27, 2022
REVERSE SHOULDER SYSTEM HUMERAL REVERSE METAPHYSIS +0MM/0
FDA Adverse Event
Injury
·MEDACTA INTERNATIONAL SA·Product code PHX·March 9, 2021
CAREEVENT REL A.0
FDA Adverse Event
Injury
·PHILIPS MEDICAL SYSTEMS·Product code MSX·March 21, 2018
Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014